Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.
Added to Watch List November 2019 @$0.55.
Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021 @$1.80Cash has Risen From $3.3 Million...
Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.
Contactless Health Screening
Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological Vitals From Vastmindz; Prepares To Run...
Draganfly (DPRO) Shareholder Call Today, 4PM EST.
https://youtu.be/SwKfEfKi8rU
Shareholder update call today August 12, 2021 at 2PM MST / 4PM EST.
The shareholder update call will be facilitated by Draganfly CEO, Cameron Chell,...
Dyadic (DYAI) Scores $10M deal with Sorrento Therapeutics (SNRE).
Share Price up 27% ($4.63 up $1.04) as Wall Street Sorts out the Terms of the Deal.
We've had a Long History With Dyadic Dating...
Draganfly (DPRO) the Tesla of Drones, Locked and Loaded.
Closes $20 Million Raise.Uplists to NASDAQ.Pilot Training for First Responders Firefighters, Search and Rescue Commences.Reports Record Revenues for Second Quarter.Shareholder Update and Earnings Call...
Hapbee (HAPB) Expands Leadership Team to Support Aggressive Growth Strategy
VANCOUVER, BC, Aug. 6, 2021 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company"), the leading wearable, wellness technology company has announced the appointment...
Draganfly (DPRO) Closes $20 Million Public Offering. Now NASDAQ Listed.
Los Angeles, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (Nasdaq: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), a drone manufacturer...
With Hapbee (HAPBF) Who Needs, Drugs, Caffeine or Nicotine?
Record 1 Million Hours of Mood Stimulation Served by Hapbee (HAPBF).
TRADING AT THE LOWER END OF YEAR LONG CHANNEL, HAPBEE OFFER AN EXCELLENT ENTRY...
Are Psychedelics the New Prozac?
Amidst a national epidemic of opioid abuse, and suicides the need for new therapeutics has gained greater urgency. In it's first step to meet this...
Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.
Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target.
REPORT
LIVE QUOTE
INVESTOR DECK
Latest article
Jeffrey Gundlach: Reckoning is Coming.
Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm.
On 11 November 2020, Gundlach remarked in an interview with...
Who’s the Next Eric Sprott?
Eric Sprott, on Who is the Next Eric Sprott!
To say Eric Sprott has left a legendary mark on the world of mining investment would...
Perpetua (PPTA) Raises $300 Million.
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...
